Targeted gene therapy for cancer: Herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells

R. G. Vile, R. M. Diaz, S. Castleden, H. Chong

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Targeted gene therapy for cancer: Herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells'. Together they form a unique fingerprint.